Access to Information Requests Completed - January 2012

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

Completed Requests

For the month of January 2012

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2009-01282	Any proposed regulations pertaining to limits on the use of partially hydrogenated oils containing synthetic trans-fat and containing media communications plans, strategies, and/or advice. (Apr 1, 2009 to Feb 1, 2010).	Disclosed in part	265
A-2009-01308	Information regarding the medical device, License number 80374 by Prowital Dental Implants GMBH.	Disclosed in part	487
A-2010-00415	Notice of Allegation (pursuant to the Patented Medicines) letter dated October 1, 2009 and all attachments, in respect to the abbreviated new drug submission for a generic version of the drug pregabalin.	Disclosed in part	11
A-2010-00680	All documents relating to the 'proof of concept', testing and evaluation of Oracle Beehive.	Disclosed in part	1,522
A-2010-00800	Briefing Book prepared for Minister of Health Leona Aglukkaq's recent trip to China.	Disclosed in part	212
A-2010-01087	Information regarding the following products: - Sunyata Green Propolis (NPN 80015703) and Sunyata Pon Lee Propolis Extract 30ml (NPN 80020851) by Royal Nature Products Co. Ltd. - NPNs 80015697, 80019317, 80021292 and 80023026 by Viker Manufacturer Co. Ltd.	Disclosed in part	150
A-2010-01089	All documents about health warnings on cigarette packaging. (Nov 1, 2010 to Dec 31, 2010).	Disclosed in part	580
A-2010-01262	All documents at about the Food Regulatory Advisory Committee. (Jul 1, 2010 to Feb 7, 2011).	Disclosed in part	638
A-2010-01414	All documents regarding file 10-005778f relating to May 10, 2010 letter to Minister of Health regarding complaint violation of the Canada Health Act made on behalf of disabled Canadians.	All disclosed	63
A-2010-01421	All documents that allowed the registration of Concerta by Janssen Inc.	Disclosed in part	644
A-2010-01526	All information regarding prosecuting under the Tobacco Act tracked by Health Canada. (Jan 1, 2006 to Mar 22, 2011).	All disclosed	4
A-2010-01598	List of top-25 billing doctors and dentists, with amount they billed in 2010, under aboriginal health programs.	Disclosed in part	1
A-2011-00027	All documents in MECS for the following files: 10-121867-946, 10-120939-48, 10-006496-589 and 10-122287-154.	Disclosed in part	73
A-2011-00177	AERs. Report numbers: 00176339, 00177096, 00177137, 00177290, 00177495, 00177604, 00177608, 00177944, 00177946 and 00178410.	Disclosed in part	32
A-2011-00180	AERs. Report numbers: 00182306, 00183196, 00183475, 00183839, 00183932, 00184006, 00184118, 00184184, 00184204 and 00184322.	Disclosed in part	34
A-2011-00184	AERs. Report numbers: 00187306, 00187354, 00187587, 00187779, 00188613, 00188784, 00189088, 00189254, 00189268 and 00189308.	Disclosed in part	59
A-2011-00187	AERs. Report numbers: 00203133, 00203349, 00203350, 00203351, 00203361, 00203371, 00203901, 00204287, 00204466 and 00206708.	Disclosed in part	60
A-2011-00211	AER for the product Kaletra. Report number: 000342773.	Disclosed in part	8
A-2011-00230	Information regarding the product Praxis ASA EC 81mg Daily Low Dose, DIN 02283700 by Pharmascience Inc.	Disclosed in part	54
A-2011-00241	Information regarding the product Calcium D-Glucarate, NPN 80021334 by XXX.	Disclosed in part	31
A-2011-00339	Information regarding the product Jamp-Fer Fc, NPN 80025200 by JAMP Pharma Corporation.	Disclosed in part	50
A-2011-00354	All test reports, certificates of compliance, and all other compliance related documents for various lighter manufactures. (Jan 1, 2000 to Jun 22, 2011).	Disclosed in part	90
A-2011-00406	All documents in MECS for the following files: 11-102315-519 and 11-101134-779.	Disclosed in part	63
A-2011-00475	Statistics and all documents regarding the processing of Access to Information requests.	All disclosed	505
A-2011-00476	Copy of the contract that Prairie Plant Systems Inc., has signed with Health Canada for the cultivation and fabrication of medical marihuana.	Disclosed in part	262
A-2011-00549	All documents under the control of Health Canada that relate to the Settlement Agreement 'Entente de règlement hors cour et transaction' made July 4, 2011 between Conseil québécois sur Ie tabac et la sante, Cécilia Letourneau, Lauzon Belanger Lesperance, Trudel Johnston, De Grandpre Chait, Kugler Kandestin and Procureur general du Canada.	Disclosed in part	55
A-2011-00651	Information regarding the product Lucentis by Novartis Pharmaceuticals Canada Inc.	Disclosed in part	421
A-2011-00673	Product Monograph for the product Midazolam Injectable, DINs 02243934 and 02243935 by Novopharm Limited.	All disclosed	64
A-2011-00698	Information regarding the product Adcirca (tadalafil) by Eli Lilly Canada.	Disclosed in part	110
A-2011-00710	AERs for the product Aspirin. Report numbers: 000366765, 000368361, 000369640, 000371850, 000372088, 000372355 et 000372956.	Disclosed in part	35
A-2011-00733	Copies of all approvability (patent hold) letters sent by Health Canada - Therapeutic Products Directorate for all generic companies who have received a notice of compliance regarding finasteride.	Disclosed in part	8
A-2011-00781	AERs for the product Recombivax HB. Report numbers: 000328248 and 000353835.	Disclosed in part	6
A-2011-00797	Information regarding the products Carlson Super Daily D3 For Kids (NPN 80027333) and Carlson Super Daily D3 For Baby (NPN 80027334).	All disclosed	26
A-2011-00810	Information regarding the product Heparin Sodium Injection, DIN 02303108 by Sandoz Canada Incorporated.	Disclosed in part	3
A-2011-00813	Information regarding the product HEPARIN LEO INJECTION, DIN 00579718 by LEO PHARMA INC.	No records exist	0
A-2011-00831	Information regarding the product XYLOCAINE JELLY 2%, DIN 00001694 by AstraZeneca Canada Inc.	Disclosed in part	48
A-2011-00835	All correspondence between Health Canada officials and industry representatives pertaining to Health Canada's Expert Panel on Caffeinated Drinks. (Nov 1, 2010 to Oct 19, 2011).	Disclosed in part	1
A-2011-00844	Information regarding the product Gravol - Multi-Symptoms, NPN 80025780 by Church & Dwight Canada Corp.	Disclosed in part	372
A-2011-00865	AERs. Report numbers: 000368553, 000366146, 000367618, 000371254, 000371409, 000371534, 000368912, 000367497, 000370930, 000371828, 000370401 and 000367286.	Disclosed in part	27
A-2011-00872	All question period cards prepared for the Minister. (Sep 19, 2011 to Oct 21, 2011).	Disclosed in part	396
A-2011-00895	Information regarding the product Kripps Maca-X, NPN 80026898.	Disclosed in part	110
A-2011-00913	All documents from Jul 1, 2011 to Sep 30, 2011 (between Glenda Yeates and Minister Aglukkaq) about the China-Canada dialogue and joint meetings that occurred between Sep 3-11, 2010 (in Hong Kong, Shanghai, and Beijing).	Disclosed in part	24
A-2011-00922	All question period material prepared for the Minister and Parliamentary Secretary. (October 1-15, 2011).	Disclosed in part	87
A-2011-00925	Health Canada Reports titled: - Cannabinoids in Cosmetics, Foods and Nutraceuticals: An Assessment of the Health Risks. Health Canada, 2001, unpublished. - Health Canada. DRAFT - Tetrahydrocannabinol (THC) and Other Cannabinoids in Foods, Cosmetics and Nutraceuticals. A Risk Assessment. Health Canada, 2001, unpublished.	No records exist	0
A-2011-00954	Copy of the most recent survey regarding Cadmium in Children's jewellery.	All disclosed	12
A-2011-00960	AERs for the products Pradax and Plavix.	Disclosed in part	19
A-2011-01081	AER for the product Depakene. Report number: 000364878.	Disclosed in part	2
A-2011-01128	AER for the product Ceftriaxone.	Disclosed in part	4
A-2011-01131	All call-ups/contracts issued for Sole Source Contracting and Professional Services Online from September 2011 to November 2011.	Disclosed in part	2,570
A-2011-01134	Information regarding the product Innohep by Leo Laboratories Canada Ltd.	No records exist	0
A-2011-01138	Written document from Health Canada defining the set of criteria to determine what prescription drugs get covered by Non-Insured Health Benefits for First Nation people.	All disclosed	24
A-2011-01140	Medical device problem reports relating to the DePuy ASR Hip Systems (DEPUY ASR SYSTEM - TOTAL FEMORAL) manufactured by DePuy International Ltd. (Nov 1, 2005 to Nov 1, 2011).	No records exist	0
A-2011-01141	Medical device problem reports relating to the DePuy ASR Hip Systems (ASR XL ACETABULAR CUP SYSTEM - UNI-POLAR HEAD) manufactured by DePuy International Ltd. (Nov 1, 2005 to Nov 1, 2011).	No records exist	0
A-2011-01142	Medical device problem reports relating to the DePuy ASR Hip Systems (ASR XL ACETABULAR CUP SYSTEM - TAPERED SLEEVE ADAPTER) manufactured by DePuy International Ltd. (Nov 1, 2005 to Nov 1, 2011).	No records exist	0
A-2011-01143	Medical device problem reports relating to the DePuy ASR Hip Systems (ASR ACETABULAR CUP SYSTEM - ACETABULAR IMPLANT) manufactured by DePuy International Ltd. (Nov 1, 2005 to Nov 1, 2011).	No records exist	0
A-2011-01144	Medical device problem reports relating to the DePuy ASR Hip Systems (ASR 300 SIZE 44 ACETABULAR CUPS) manufactured by DePuy International Ltd. (Nov 1, 2005 to Nov 1, 2011).	No records exist	0
A-2011-01148	All callups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of November 2011.	Disclosed in part	77
A-2011-01149	All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of November 2011.	All disclosed	1
A-2011-01151	All call-ups and amendments issued under the terms of the TBIPS Standing Offer (EN578-055605) in the National Capital Region during the month of November 2011.	No records exist	0
A-2011-01159	AER for the product Amoxicillin.	Disclosed in part	2
A-2011-01160	AER for the product Phenytoin.	Disclosed in part	2
A-2011-01161	AER for the product Prednisolone.	Disclosed in part	2
A-2011-01170	AERs. Report numbers: 000372774 and 000367433.	Disclosed in part	15
A-2011-01171	All documents relating to pre-submission meetings or scientific advice meetings with sponsors INFLIXIMAB. (Jan 1, 2009 to Dec 9, 2011).	No records exist	0
A-2011-01174	All documents regarding the use of estrogen (including but not limited to bisphenol-A) in energy drinks and other beverages that include caffeine. (Jan 1, 2002 to Dec 6, 2011).	No records exist	0
A-2011-01176	All documents regarding the use of asparaginase in soft drinks, energy drinks and all other beverages. (Jan 1, 2008 to Dec 6, 2011).	No records exist	0
A-2011-01177	AER for the product Alvesco (ciclesonide). Report number: 000366213.	Disclosed in part	1
A-2011-01179	AER for the product Pantoloc (pantoprazole sodium). Report number: 000365461.	Disclosed in part	1
A-2011-01180	AERs for the product Tecta (pantoprazole magnesium). Report numbers: 000365534, 000366080 and 000366095.	Disclosed in part	3
A-2011-01189	All documents that lists the follow-up activities, such as research and scientific monitoring, that Health Canada has undertaken since May 15, 2006 to enhance the scientific basis for the Department's decision to exclude personnel who worked with nonhuman primates from donating blood as a precautionary measure.	No records exist	0
A-2011-01191	All documents that support the Director General's statement/contention that Health Canada's Rhesus monkeys have been tested for Simian Foamy Virus (SFV) and no SFV infections were found.	No records exist	0
A-2011-01198	All documents pertaining to the Department's rationale/justification for not allowing its employees to have total control over whether their Simian Foamy Virus (SFV) test results are or are not placed in their Health Canada medical file.	No records exist	0
A-2011-01209	Report Listing TBIPS in the National Capital Region from January 2011 to November 2011.	All disclosed	1
A-2011-01214	Number of SAP releases for the following drug for the months of January, February, March, April and May 2011: Bendamustine.	All disclosed	1
A-2011-01215	Number of SAP releases for the following drug for the months of January and February 2011: Halaven (eribulin mesylate).	All disclosed	1
A-2011-01218	AERs for the product Lipidil. Report numbers: 000364641 and 000369591.	Disclosed in part	3
A-2011-01220	Information regarding the product ONBREZ (Indacaterol Maleate), DIN 02376938 by Novartis Pharmaceuticals Canada.	All exempted	0
A-2011-01223	AERs for the product CLEAN & CLEAR ADVANTAGE ACNE SPOT TREATMENT. Report numbers: 000335798 and 000335999.	Disclosed in part	2
A-2011-01225	Information regarding the product colloidal silver by Nature Beauté Santé Inc.	No records exist	0
A-2011-01226	Risk assessment from lead exposure from race cars.	All disclosed	27
A-2011-01227	AER for the product Xarelto. Report number: 000374658.	Disclosed in part	2
A-2011-01228	AER for the product Magnevist. Report number: 000375231.	Disclosed in part	1
A-2011-01229	AER for the product Levitra. Report number: 000374004.	Disclosed in part	1
A-2011-01230	AER for the product Kogenate. Report number: 000374488.	Disclosed in part	1
A-2011-01231	AER for the product Gadovist. Report number: 000373823.	Disclosed in part	1
A-2011-01232	AER for the product Cipro. Report number: 000374196.	Disclosed in part	1
A-2011-01233	AERs for the product Avelox. Report numbers: 000373236, 000373481, 000374049, 000375137, 000375140 and 000375366.	Disclosed in part	7
A-2011-01234	AERs for the product Adalat. Report numbers: 000374532 and 000374532.	Disclosed in part	2
A-2011-01235	AERs for the product Yaz. Report numbers: 000373851, 000374166 and 000374517.	Disclosed in part	3
A-2011-01236	AERs for the product Yasmin. Report numbers: 000372929, 000373634 and 000374659.	Disclosed in part	4
A-2011-01261	AER for the product ZOLOFT.	Disclosed in part	2
A-2011-01262	AER for the product TAZOCIN.	Disclosed in part	4
A-2011-01263	AER for the product CYTOSAR.	Disclosed in part	2
A-2011-01264	AER for the product DILANTIN.	Disclosed in part	2
A-2011-01271	Previously released request A-2009-00414: Information regarding adverse event reports in relation to energy drinks.	Disclosed in part	204
A-2011-01273	All information not posted on your website along with any/all information that was provided on your website from 1982 to 2004; related to adverse reactions to Accutane resulting in Inflammatory Bowel Disease, Chron's Disease, Colitis, and Stevens - Johnson syndrome.	No records exist	0
A-2011-01274	All documents regarding to the use of steroids in hockey. (Nov 1, 2008 to Nov 30, 2011).	No records exist	0
A-2011-01288	Number of SAP releases for the following drug for the month of December 2011: Treanda.	All disclosed	1
A-2011-01290	Number of SAP releases for the following drug for the month of December 2011: Targretin.	All disclosed	1
A-2011-01291	Number of SAP releases for the following drug for the month of December 2011: Dacogen.	All disclosed	1
A-2011-01293	Number of SAP releases for the following drug for the month of December 2011: Carfilzomib.	No records exist	0
A-2011-01294	Number of SAP releases for the following drug for the month of December 2011: Folotyn.	All disclosed	1
A-2011-01295	Number of SAP releases for the following drug for the month of December 2011: Zolinza.	All disclosed	1
A-2011-01298	Number of SAP releases for the following drug for the month of December 2011: Afatinib.	All disclosed	1
A-2011-01299	Number of SAP releases for the following drug for the month of December 2011: Prochymal.	No records exist	0
A-2011-01301	Number of SAP releases for the following drug for the month of December 2011: Halaven.	All disclosed	1
A-2011-01303	Number of SAP releases for the following drug for the month of December 2011: Cabazitaxel.	All disclosed	1
A-2011-01307	Number of SAP releases for the following drug for the month of December 2011: Belinostat.	No records exist	0
A-2011-01310	Number of SAP releases for the following drug for the month of December 2011: Campath.	All disclosed	1
A-2011-01313	Copies of the user contracts attached to implantable medical devices. (Jan 1, 2010 to Jan 31, 2011).	No records exist	0
A-2011-01315	Number of SAP releases for the following drug for the month of December 2011: Feraheme.	No records exist	0
A-2011-01317	Number of SAP releases for the following drug for the month of December 2011: Bendamustine.	All disclosed	1
A-2011-01318	Number of SAP releases for the following drug for the month of December 2011: Brentuximab.	No records exist	0
A-2011-01337	Number of SAP releases for the following drug for the month of October 2011: Bendamustine.	All disclosed	1
A-2011-01338	Number of SAP releases for the following drug for the year 2010: Brentuximab.	No records exist	0
A-2011-01355	All callups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of January to October 2011.	Disclosed in part	683
A-2011-01383	Previously released request A-2007-00714: Information regarding the allocation of the $84.4 million Federal Strategy to Address HIV/AIDS in Canada.	Disclosed in part	171